Dr Sanjiv Agarwal has over two decades of experience in healthcare leadership and innovation, with dual accreditation in healthcare and management. As the Skin Cancer Lead and Governance Lead at Milton Keynes University Hospital NHS Foundation Trust, Dr Agarwal has led initiatives that have elevated the Dermatology department to one of the top performers nationally in achieving skin cancer targets. He oversees the management of skin cancer cases, complex inflammatory dermatoses, governance frameworks, and community awareness and prevention strategies. Dr Agarwal holds memberships with esteemed professional organisations, including being a Member of the Royal College of Physicians and a Fellow of the Royal Society of Medicine, underscoring his commitment to excellence in clinical practice and leadership.
In his role as Clinical Lead in Dermatology at DMC Healthcare, Dr Agarwal has introduced innovative service models, including teledermatology solutions, to expand access to specialised care in underserved regions. His contributions include establishing robust clinical governance frameworks, launching teledermatology platforms, and implementing quality assurance protocols, significantly improving patient access, diagnostic accuracy, and outcomes.
Dr Agarwal is also the Founder and Managing Director of Diabetacare, where he has pioneered connected healthcare services, including Remoted Care Monitoring®, to revolutionise diabetes management. His leadership reflects a commitment to bridging gaps in traditional service models and enhancing patient outcomes. Additionally, he has worked with Apnee Sehat and Hertfordshire Community NHS Trust, promoting culturally sensitive healthcare and innovative service delivery.
Dr Agarwal founded and led 4 Ways Healthcare, the largest subspecialty teleradiology provider in the UK. Under his leadership, the company became a model of successful public-private partnership, achieving the highest clinical quality and earning Imaging Service Accreditation from the Royal College of Radiologists within its first five years.